semaglutide fybeca Rybelsus (Semaglutide Tablets) in Canada for Diabetes Management Aviso a la comunidad📢

Participants also saw significant reductions in hemoglobin A1C (a measure of blood sugar) and blood pressure, improved HDL cholesterol levels and lower 10-year cardiovascular disease risk scores

Understanding how these two conditions may interact is essential for safe prescribing and patient counseling, particularly as semaglutide becomes increasingly prescribed for weight management in diverse patient populations

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program provided the primary evidence base, showing continued efficacy without significant safety concerns emerging over extended use

The company estimates that more than 50% of patients taking GLP-1 drugs stop because of costs, while more than a third do so because of side effects